This page contains brief details about the drug , it's indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Background and Date of Approval
Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate belongs to the therapeutic class of Anti-ulcerate.
Mechanism of Action of undefined
Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate forms a protective layer on the gastrointestinal lining, safeguarding it from the corrosive impact of stomach acid. This action helps to alleviate symptoms like stomach pain and inflammation. Additionally, it exhibits antimicrobial properties, aiding in treating gastrointestinal infections by controlling bacterial growth.
Uses of undefined
Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate is commonly used to treat various gastrointestinal disorders. Its primary applications include managing conditions such as gastritis, peptic ulcer disease, dyspepsia (indigestion), and reflux esophagitis.
undefined Drug administaration and Dosage available
Tripotassium dicitrato bismuthate is typically administered orally. It is commonly available as a tablet or liquid suspension for oral ingestion. The best route of administration depends on the individual's needs and preferences, but oral administration is typically the most convenient.
Warnings, Precautions and Side Effects of undefined
Warnings
Prolonged or excessive use of Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate can lead to bismuth toxicity, which may manifest as symptoms like neurotoxicity, kidney damage, or other serious adverse effects. Although it is used to treat gastrointestinal conditions, it may mask symptoms of more serious underlying issues such as gastric malignancy.
Precautions
It is crucial to adhere to the recommended dosage of Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate and not exceed the prescribed duration of use. Thus, if symptoms of gastrointestinal conditions persist or worsen despite treatment, further investigation may be necessary.
Side Effects
Side effects of Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate may include both common and rare reactions. Common side effects can encompass a harmless darkening of the tongue and stool, as well as gastrointestinal disturbances like constipation or diarrhoea. On the other hand, rare but potentially severe side effects may include allergic reactions, presenting as skin rashes, itching, swelling, or difficulties in breathing.
Word Of Advice
First, individuals with a known allergy to Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate and its components should avoid its use. Caution is advised for those with severe kidney or liver problems, as the medication may further impact organ function. Pregnant or breastfeeding individuals should avoid using this medication without medical guidance. Similarly, caution is advised for children and individuals with lung conditions. Alcohol consumption should be limited or avoided, as it may interact with the drug. Finally, users should be cautious while driving or operating machinery, as the medication may cause dizziness or drowsiness. Generally, consulting a healthcare professional for personalised guidance and adhering to the prescribed dosage and usage instructions is crucial.
Frequently Asked Question
References
- Burgundy Sweet, Upper Gastrointestinal Disorders, Handbook of Applied Therapeutics, 9th Edition, 2016, 245-256.
- I V Maev et al., Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease, Klin Med (Mosk), 2008, 86(9):57-63 [Accessed on 16th Oct 2023] https://pubmed.ncbi.nlm.nih.gov/19048841/
- Thomas et al., Medical Use of Bismuth: the Two Sides of the Coin, J Clinic Toxicol, 2011, [Accessed on 16th Oct 2023] https://www.longdom.org/open-access/medical-use-of-bismuth-the-two-sides-of-the-coin-2161-0495.S3-004.pdf
Disclaimer
The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.
